2 High-Octane Cannabis Stocks to Buy in October for Aggressive Investors

Innovative Industrial Properties (IIPR) and Trulieve Cannabis (TRLV) reported higher Q2 profits. IIPR's revenue was $63.3M, AFFO per share $1.83. TRLV's revenue was $271M, EPS $0.11. Both stocks are up YTD, with TRLV +28%. They have strong balance sheets and shareholder-friendly policies, but face industry risks.

Original reporting
Published Oct 3, 2026, 11:20 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 3, 2026, 12:35 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
2 High-Octane Cannabis Stocks to Buy in October for Aggressive Investors — source image
Decision brief

The 30-second read

$IIPRBullishMed
01

Why it matters

Both firms delivered earnings improvements that may attract income‑focused and growth‑oriented investors, though sector risks persist.

02

Market read

Earnings beats and cash‑return actions could drive short‑term price gains in the niche cannabis sector.

03

What to watch

Regulatory uncertainty around Schedule III rescheduling and state‑level tax burdens remain key risks.

Relevance 6/10Novelty 6/10Timing: post‑market today

Background

The article reviews two cannabis companies, highlighting their Q2 financial results, dividend yields, and buyback activity.

Company-level read

Ticker impact

$IIPRBullishMedium confidence
Context

Innovative Industrial reported Q2 revenue of $63.3M and AFFO of $1.83 per share, a 7% year‑over‑year increase.

Expected impact

likely upward pressure as investors price in the earnings beat and high dividend yield

Evidence & confidence

Q2 results exceed prior year and AFFO growth supports dividend sustainability, though payout ratio is high.

$TRLVBullishMedium confidence
Context

Trulieve posted Q2 revenue of $271M (down 10%) and adjusted EPS of $0.11, up from a loss a year ago.

Expected impact

potential upside as the market rewards earnings improvement and buyback announcement

Evidence & confidence

Improved EPS and a $50M buyback signal stronger cash flow, offset by margin pressure.

Market effects

Positive earnings may lift sentiment across the cannabis REIT and retail segments.

U.S. cannabis stocks could see broader buying interest.

Limited to investors focused on U.S. cannabis exposure.

Counterpoint

High dividend payout ratio at IIPR and margin compression at TRLV could pressure shares if earnings guidance softens.

Key entities

  • Innovative Industrial Properties

    US‑listed REIT focused on cannabis real estate.

  • Trulieve Cannabis

    US‑listed cannabis retailer with recent NYSE listing.

Related articles

$IIPRMedAI 8/10

Innovative Industrial Properties, Inc. and IIP Operating Partnership, LP entered into amendments to each of the Company's existing equity distribution…

INNOVATIVE INDUSTRIAL PROPERTIES INC (IIPR) filed an SEC Form 8-K — Other Events. Item 8.01 Other Events. On November 9, 2026, Innovative Industrial Properties, Inc. (the “Company”) and IIP Operating Partnership, LP entered into amendments (collectively, the “Amendments”) to each of the Company's existing equity distribution agreements with BTIG, LLC, Piper Sa

$TRLVHigh

Trulieve (TRLV) Q3 2026 Earnings Call Transcript

Trulieve (TRLV) reported Q3 2026 earnings exceeding guidance, with $230M revenue (4% YoY growth), 64% gross margin, and $89M adjusted EBITDA. The company benefited from federal rescheduling of medical marijuana to Schedule III, enabling DEA registration, tax relief, and NYSE listing. Trulieve also repaid $65M in debt, improving cash flow. The company is expanding in Georgia and Texas, with strategic initiatives focused on access, growth, and product portfolio.

$TRLVHigh

Trulieve Reports Third Quarter 2026 Results

Trulieve Cannabis Corp. (TRLV) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 Trulieve Reports Third Quarter 2026 Results • Third quarter revenue of $230 million, with 64% gross margin • Cash flow from operations of $183 million and free cash flow of $120 million* in first nine months of 2026 • Received final DEA registrations pursuant to fina